Media Alert: Reval To Testify Before U.S. Senate on OTC Derivatives Reform

--()--Reval:

“OTC Derivatives Reform and Addressing Systemic Risk.”

Who:

     

Jiro Okochi, chief executive officer and co-founder of Reval, a derivative risk

management and hedge accounting company which helps over 375 public

companies manage and account for the OTC derivatives they use to hedge
specific business risks in interest rates, foreign exchange and commodities.
 

What:

Will testify before the U.S. Senate Committee on Agriculture, Nutrition, and

Forestry in a hearing on “OTC Derivatives Reform and Addressing Systemic Risk.” See

http://ag.senate.gov/site/calendar.html

 

When:

Wednesday, December 2, 2009 from 9:30 am to 11:30 am ET
 

Where:

216 Hart Senate Office Building, Washington, DC; see map at

http://www.visitthecapitol.gov/Visit/Capitol%20Complex%20Map/

 

PR Contact:

For interviews with Jiro Okochi following the hearing, please contact Zoe Sochor at

zoe.sochor@reval.com, +1 860 799 7076

Contacts

Reval
Public Relations
Zoe Sochor, +1 860 799 7076
zoe.sochor@reval.com
or
North America
Tracy Kantrowitz, +1 212 901 9711
tracy.kantrowitz@reval.com
or
EMEA and APAC
Brendan Nel, +44 (0) 207 868 5249
brendan.nel@reval.com

Better Be Business Wired.

Business Wire is the leading source for press releases, photos, multimedia and regulatory filings from companies and groups throughout the world.